Avaxia Biologics
Avaxia Biologics (www.avaxiabiologics.com) is a private, early stage company developing orally-delivered antibody therapeutics using a proprietary antibody platform. The company is pursuing products for oral mucositis, inflammatory bowel disease,...Homepage: http://www.avaxiabiologics.com/
Total money raised: $5.6M
02421
128 Spring Street
Suite 620
Lexington
USA MA
Suite 620
Lexington
USA MA
Phone: 781-861-0062
Updated on Mar 19, 2012
Avaxia Biologics at CrunchBase
Barbara S. Fox CEOAvaxia Biologics at CrunchBase
David C. Dlesk COO
Past
March, 2012
Avaxia Biologics raised $1.5M in grant round
Avaxia Biologics Adds $1.5M From Phase II NIH Grant 
fis.dowjones.com
February, 2012
Avaxia Biologics raised $4.1M in a Series A round from Cherrystone, Boston Harbor Angels, Beacon Angels, LaunchPad Venture Group, Mass Medical Angels, and North Country Angels
Avaxia Biologics Completes $4.1M Series A Financing 
finsmes.com